Allogene Therapeutics (ALLO) BV/share US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| BV/share, rub | 6.81 | 4.66 | 3.26 | 2.17 | 1.33 | 1.16 | |||
| Changes by years, y/y, % | -24% | -32% | -30% | -34% | -39% | -31.8% | |||
Allogene Therapeutics. BV/share, rub
Allogene Therapeutics. BV/share, changes, %
Allogene Therapeutics (ALLO) BV/share US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| BV/share, rub | 1.79 | 1.57 | 1.42 | 1.33 | 1.16 | 1.16 | ||
| Changes by years, y/y, % | -34% | -42% | -36% | -34% | -35% | |||
| Changes by quarters, q/q, % | -11% | -12% | -10% | -7% | -12% | |||